Immunosuppressive therapy with rituximab in common variable immunodeficiency

Immunosuppressive therapy with rituximab in common variable immunodeficiency

Abstract Common variable immunodeficiency (CVID) is the most frequent symptomatic primary antibody deficiency in adulthood and is characterized by the marked reduction of IgG and IgA serum levels. Thanks to the successful use of polyvalent immunoglobulin replacement therapy to treat and prevent recu...

Full description

Bibliographic Details
Main Authors: Antonio Pecoraro, Ludovica Crescenzi, Maria Rosaria Galdiero, Giancarlo Marone, Felice Rivellese, Francesca Wanda Rossi, Amato de Paulis, Arturo Genovese, Giuseppe Spadaro
Format: Article
Language:English
Published: BMC 2019-05-01
Series:Clinical and Molecular Allergy
Subjects:
Common variable immunodeficiency
Antibody deficiency
Autoimmune cytopenias
Granulomatous lymphocytic interstitial lung disease
Rituximab
Anti-CD20
Online Access:http://link.springer.com/article/10.1186/s12948-019-0113-3

Internet

http://link.springer.com/article/10.1186/s12948-019-0113-3

Similar Items